CU24473B1 - Composición vacunal que comprende un péptido secretagogo de la hormona de crecimiento como adyuvante vacunal - Google Patents
Composición vacunal que comprende un péptido secretagogo de la hormona de crecimiento como adyuvante vacunalInfo
- Publication number
- CU24473B1 CU24473B1 CU2016000161A CU20160161A CU24473B1 CU 24473 B1 CU24473 B1 CU 24473B1 CU 2016000161 A CU2016000161 A CU 2016000161A CU 20160161 A CU20160161 A CU 20160161A CU 24473 B1 CU24473 B1 CU 24473B1
- Authority
- CU
- Cuba
- Prior art keywords
- vaccine
- growth hormone
- composition including
- vaccine composition
- peptide
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title abstract 4
- 102000018997 Growth Hormone Human genes 0.000 title 1
- 108010051696 Growth Hormone Proteins 0.000 title 1
- 239000000122 growth hormone Substances 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 230000000580 secretagogue effect Effects 0.000 title 1
- 239000012646 vaccine adjuvant Substances 0.000 title 1
- 229940124931 vaccine adjuvant Drugs 0.000 title 1
- 239000002671 adjuvant Substances 0.000 abstract 2
- 108010015153 growth hormone releasing hexapeptide Proteins 0.000 abstract 2
- 241000894006 Bacteria Species 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 230000006806 disease prevention Effects 0.000 abstract 1
- 244000078703 ectoparasite Species 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 239000012678 infectious agent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/25—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0003—Invertebrate antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
- A61K39/165—Mumps or measles virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Endocrinology (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Fodder In General (AREA)
Abstract
<p>La presente invención se relaciona con una composición vacunal que comprende el péptido GHRP-6 o un análogo estructural de este como adyuvantes moleculares para vacunas. Entre otras aplicaciones, dichas vacunas pueden emplearse en Ia prevención de enfermedades causadas por agentes infecciosos, tales como virus, bacterias y ectoparásitos, que afectan a los mamíferos, las aves y a organismos acuáticos. Los péptidos GHRP-6 y su análogo A233 son eficaces como adyuvantes cuando se combinan con un antígeno dado, ya que potencian Ia respuesta inmune específica contra el mismo.</p>
Priority Applications (12)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CU2016000161A CU24473B1 (es) | 2016-11-01 | 2016-11-01 | Composición vacunal que comprende un péptido secretagogo de la hormona de crecimiento como adyuvante vacunal |
US16/346,034 US11179455B2 (en) | 2016-11-01 | 2017-10-30 | Use of a growth hormone secretagogue peptide as a vaccine adjuvant |
BR112019008624A BR112019008624A2 (pt) | 2016-11-01 | 2017-10-30 | uso de um peptídeo secretagogo do hormônio do crescimento, composição de vacina, e, método para melhorar a resposta imune contra um antígeno de vacina. |
KR1020197015515A KR102557023B1 (ko) | 2016-11-01 | 2017-10-30 | 성장 호르몬 분비 촉진제 펩타이드의 백신 어쥬번트로의 용도 |
CA3041944A CA3041944A1 (en) | 2016-11-01 | 2017-10-30 | Use of a growth hormone secretagogue peptide as a vaccine adjuvant |
RU2019116732A RU2768134C2 (ru) | 2016-11-01 | 2017-10-30 | Применение пептида, усиливающего секрецию соматотропного гормона, в качестве адъюванта вакцины |
PCT/CU2017/050006 WO2018082719A1 (es) | 2016-11-01 | 2017-10-30 | Uso de peptido secretagogo de la hormona de crecimiento como adyuvante vacunal |
MX2019005122A MX2019005122A (es) | 2016-11-01 | 2017-10-30 | Uso de peptido secretagogo de la hormona de crecimiento como adyuvante vacunal. |
AU2017353072A AU2017353072A1 (en) | 2016-11-01 | 2017-10-30 | Use of a growth hormone secretagogue peptide as a vaccine adjuvant |
EP17817647.5A EP3536338A1 (en) | 2016-11-01 | 2017-10-30 | Use of a growth hormone secretagogue peptide as a vaccine adjuvant |
JP2019522853A JP7079778B2 (ja) | 2016-11-01 | 2017-10-30 | ワクチンアジュバントとしての成長ホルモン分泌促進因子ペプチドの使用。 |
CL2019001191A CL2019001191A1 (es) | 2016-11-01 | 2019-04-30 | Uso de peptido secretagogo de la hormona de crecimiento como adyuvante vacunal. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CU2016000161A CU24473B1 (es) | 2016-11-01 | 2016-11-01 | Composición vacunal que comprende un péptido secretagogo de la hormona de crecimiento como adyuvante vacunal |
Publications (2)
Publication Number | Publication Date |
---|---|
CU20160161A7 CU20160161A7 (es) | 2018-06-05 |
CU24473B1 true CU24473B1 (es) | 2020-02-04 |
Family
ID=60765568
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CU2016000161A CU24473B1 (es) | 2016-11-01 | 2016-11-01 | Composición vacunal que comprende un péptido secretagogo de la hormona de crecimiento como adyuvante vacunal |
Country Status (12)
Country | Link |
---|---|
US (1) | US11179455B2 (es) |
EP (1) | EP3536338A1 (es) |
JP (1) | JP7079778B2 (es) |
KR (1) | KR102557023B1 (es) |
AU (1) | AU2017353072A1 (es) |
BR (1) | BR112019008624A2 (es) |
CA (1) | CA3041944A1 (es) |
CL (1) | CL2019001191A1 (es) |
CU (1) | CU24473B1 (es) |
MX (1) | MX2019005122A (es) |
RU (1) | RU2768134C2 (es) |
WO (1) | WO2018082719A1 (es) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CU23016A1 (es) | 2002-01-24 | 2005-01-25 | Ct Ingenieria Genetica Biotech | Método para la estimulación del crecimiento y resimétodo para la estimulación del crecimiento y resistencia a enfermedades en organismos acuáticos y fstencia a enfermedades en organismos acuáticos y formulación veterinaria ormulación veterinaria |
CU23558A1 (es) * | 2006-02-28 | 2010-07-20 | Ct Ingenieria Genetica Biotech | Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento |
EP2446898A1 (en) * | 2010-09-30 | 2012-05-02 | Laboratorios Del. Dr. Esteve, S.A. | Use of growth hormone to enhance the immune response in immunosuppressed patients |
-
2016
- 2016-11-01 CU CU2016000161A patent/CU24473B1/es unknown
-
2017
- 2017-10-30 EP EP17817647.5A patent/EP3536338A1/en active Pending
- 2017-10-30 AU AU2017353072A patent/AU2017353072A1/en not_active Abandoned
- 2017-10-30 WO PCT/CU2017/050006 patent/WO2018082719A1/es unknown
- 2017-10-30 BR BR112019008624A patent/BR112019008624A2/pt unknown
- 2017-10-30 KR KR1020197015515A patent/KR102557023B1/ko active IP Right Grant
- 2017-10-30 CA CA3041944A patent/CA3041944A1/en active Pending
- 2017-10-30 RU RU2019116732A patent/RU2768134C2/ru active
- 2017-10-30 MX MX2019005122A patent/MX2019005122A/es unknown
- 2017-10-30 US US16/346,034 patent/US11179455B2/en active Active
- 2017-10-30 JP JP2019522853A patent/JP7079778B2/ja active Active
-
2019
- 2019-04-30 CL CL2019001191A patent/CL2019001191A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
WO2018082719A1 (es) | 2018-05-11 |
KR102557023B1 (ko) | 2023-07-19 |
CA3041944A1 (en) | 2018-05-11 |
BR112019008624A2 (pt) | 2019-07-09 |
MX2019005122A (es) | 2019-06-20 |
CL2019001191A1 (es) | 2019-10-04 |
RU2768134C2 (ru) | 2022-03-23 |
JP2020500842A (ja) | 2020-01-16 |
KR20190079648A (ko) | 2019-07-05 |
CU20160161A7 (es) | 2018-06-05 |
RU2019116732A (ru) | 2020-12-03 |
US20200353065A1 (en) | 2020-11-12 |
EP3536338A1 (en) | 2019-09-11 |
AU2017353072A1 (en) | 2019-05-23 |
US11179455B2 (en) | 2021-11-23 |
JP7079778B2 (ja) | 2022-06-02 |
RU2019116732A3 (es) | 2021-02-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO2017007293A2 (es) | Dinucleótidos cíclicos útiles para el tratamiento de (inter alia) cáncer | |
CL2018002394A1 (es) | Subunidades de vacunas de inmersión para peces que comprenden al menos un antígeno aislado de la proteína análoga a histona (hlp) y su uso contra bacterias como flavobacterium. (divisional solicitud 2015000771) | |
AR089797A1 (es) | Vacunas contra clostridum difficile que comprenden toxinas recombinantes | |
BRPI0920240B8 (pt) | composição adjuvante | |
WO2016007576A8 (en) | Novel vaccine compositions for porcine epidemic diarrhea virus and porcine deltacoronavirus | |
EA201391515A1 (ru) | Инактивированная вакцина вируса денге | |
DOP2011000268A (es) | Vacuna inactivada del virus del dengue con un adjuvante libre de aluminio | |
AR081856A1 (es) | Vacuna y metodos para reducir una infeccion por campylobacter | |
CL2012000447A1 (es) | Composición o vacuna que comprende un vector viral de un paramixovirus aviar 8 (apmv-8) recombinante; método para producir dicho vector; y uso para preparar medicamento útil para inducir una respuesta inmunológica. | |
BR112016006192A2 (pt) | composição de vacina de divergente de pcv2b e métodos de uso | |
CL2015002741A1 (es) | Composiciones y métodos para aumentar la respuesta inmune contra patógenos entéricos | |
AR101814A1 (es) | Partícula de tipo virus flavivirus | |
CO7461133A2 (es) | Parvovirus 5a porcino, métodos de uso y vacuna | |
EA201991041A1 (ru) | Вакцина против свиного парвовируса и вируса свиного репродуктивного и респираторного синдрома и способы ее получения | |
CL2021003211A1 (es) | Una cepa viva modificada, del virus del síndrome respiratorio y reproductivo porcino (prrs), vacuna que lo comprende y su uso para tratar el prrs tipo ii. (divisional solicitud no. 2123-2018) | |
CO7461135A2 (es) | Parvovirus porcino 5b, métodos de uso y vacuna | |
AR097029A1 (es) | Aceleración de la respuesta inmune inducida por virus vectorial en aves, composición, uso, método para la vacunación y método para acelerar la respuesta inmune | |
MY167069A (en) | Antigen peptide and use thereof | |
AR083766A1 (es) | Peptido inmunogenico | |
AR088176A1 (es) | Secuencias de aminoacidos para el control de patogenos | |
CU24473B1 (es) | Composición vacunal que comprende un péptido secretagogo de la hormona de crecimiento como adyuvante vacunal | |
CU24075B1 (es) | Composición vacunal que comprende el péptido activador de la adenilato ciclasa de pituitaria como adyuvante molecular. | |
EA202090236A1 (ru) | Иммуногенные композиции senecavirus a и способы с ними | |
ECSP21042530A (es) | Composición homeopática a base de veneno de escorpión rhopalurus junceus y su uso en acuicultura | |
CL2017002972A1 (es) | Péptido anti microbiano del tipo nk-lisina, para el control de agentes patógenos y su uso como adyuvante molecular. |